These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 815171)

  • 1. Evidence for a serum inhibitor of Clq.
    Conradie JD; Volanakis JE; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):967-71. PubMed ID: 815171
    [No Abstract]   [Full Text] [Related]  

  • 2. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
    Kolb WP; Kolb LM; Podack ER
    J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the activation of C1 in serum.
    Faulmann EL; Boyle MD
    Mol Immunol; 1987 Jun; 24(6):655-60. PubMed ID: 3657802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of concanavalin A on the early components of the complement system.
    Scott GK; Fothergill JE
    Immunochemistry; 1975 Nov; 12(11):909-10. PubMed ID: 1218891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired C1-esterase inhibitor deficiencies during lymphoid syndromes].
    Oberling F; Hauptmann G; Lang JM; Bergerat JP; Mayer G; Batzenschlager A; Hammann B; Gillet B
    Nouv Presse Med; 1975 Nov; 4(38):2705-8. PubMed ID: 812065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 inhibitor.
    Davis AE; Aulak KS; Zahedi K; Bissler JJ; Harrison RA
    Methods Enzymol; 1993; 223():97-120. PubMed ID: 8271970
    [No Abstract]   [Full Text] [Related]  

  • 8. C1 inactivator.
    Harpel PC
    Methods Enzymol; 1976; 45():751-50. PubMed ID: 1012031
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of Cl, the first component of complement, the generation of Clr-Cls and Cl- inactivator complexes in normal serum by heparin-affinity chromatography.
    McKay EJ; Laurell AB; Mårtensson U; Sjöholm AG
    Mol Immunol; 1981 May; 18(5):349-57. PubMed ID: 6273714
    [No Abstract]   [Full Text] [Related]  

  • 10. A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.
    Reboul A; Arlaud GJ; Sim RB; Colomb MG
    FEBS Lett; 1977 Jul; 79(1):45-50. PubMed ID: 891934
    [No Abstract]   [Full Text] [Related]  

  • 11. C1 inhibitor: quantification and purification.
    Varga L; Dobó J
    Methods Mol Biol; 2014; 1100():189-205. PubMed ID: 24218261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-associated plasma protein-A: an inhibitor of the complement system.
    Bischof P
    Placenta; 1981; 2(1):29-34. PubMed ID: 6163148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the enzymatic activity of the first component of complement (C1) by heparin.
    Strunk R; Colten HR
    Clin Immunol Immunopathol; 1976 Sep; 6(2):248-55. PubMed ID: 963916
    [No Abstract]   [Full Text] [Related]  

  • 14. C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Pathol Biol (Paris); 1975 Dec; 23 suppl():33-6. PubMed ID: 817252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin associated with Clq in a Clq isolation procedure.
    Anderson B; Entwistle R; Puyat L; Davis L; Schmid FR
    Immunol Commun; 1981; 10(8):687-96. PubMed ID: 6804372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
    Teshima H; Wanebo H; Pinsky C; Day NK
    J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
    Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
    Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.